Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement
JACC: Cardiovascular Interventions · 2024-11 · 17 (22) · 2626-2635
DOI: 10.1016/j.jcin.2024.08.041 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2024-11. Verfasst von Henning Guthoff und 45 weiteren Autor:innen. Beteiligte Einrichtung: University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany. Hauptthemen laut MEDLINE: Aortic Valve, Aortic Valve Stenosis, Heart Valve Prosthesis, Predictive Value of Tests. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
BACKGROUND: Prosthesis-patient mismatch after transcatheter aortic valve replacement (TAVR) can be measured echocardiographically (measured prosthesis-patient mismatch [PPMm]) or predicted (predicted prosthesis-patient mismatch [PPMp]) using published effective orifice area (EOA) reference values. However, the clinical implications of PPM post-TAVR remain unclear. OBJECTIVES: This study aimed to elucidate the prevalence of PPMm and PPMp post-TAVR and their impact on mortality in a large international cohort. METHODS: The IMPPACT TAVR (Impact of Measured or Predicted Prosthesis-pAtient mismatCh after TAVR) registry included 38,808 TAVR patients from 26 international centers. Valve Academic Research Consortium 3 criteria were used to define prosthesis-patient mismatch severity. EOA was determined echocardiographically (PPMm) or predicted (PPMp) based on core lab-derived EOA reference values. The primary endpoint was 2-year all-cause mortality. RESULTS: The prevalence of PPMp (moderate: 6.8%, severe: 0.6%) was significantly lower than that of PPMm (moderate: 20.7%, severe: 4.3%; P < 0.001) with negligible correlation between the 2 methods (Kendall's tau c correlation coefficient: 0.063; P < 0.001). In unadjusted analyses, severe PPMm adversely influenced 2-year survival (HR: 1.22; 95% CI: 1.02-1.45; P = 0.027), whereas severe PPMp was not associated with outcomes (HR: 0.81; 95% CI: 0.55-1.19; P = 0.291). After adjusting for confounders, neither PPMm nor PPMp had a significant effect on 2-year all-cause mortality. CONCLUSIONS: PPMm and PPMp were associated with different patient characteristics, with PPMm tending toward worse (especially low flow) and PPMp toward better (especially women) survival. After adjusting for confounders, neither PPMm nor PPMp significantly affected 2-year all-cause mortality. Hence, valve selection should not solely be based on hemodynamics but rather on a holistic approach, including patient and procedural specifics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University of Cologne, Faculty of Medicine and University Hospital Cologne, Clinic III for Internal Medicine, Cologne, Germany.
- Department of Cardiology, Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
- Kerckhoff Heart Center, Department of Cardiology, Bad Nauheim, Germany; Kerckhoff Heart Center, Department of Cardiac Surgery, Bad Nauheim, Germany; Justus-Liebig University of Giessen, Department of Cardiology, Giessen…
- Division of Cardiology, Rabin Medical Center, Petah-Tikva, Israel.
- Department of Statistics, Technical University Dortmund University, Dortmund, Germany.
- Heart Center, Department of Medicine II, University Hospital Bonn, Bonn, Germany.
Zitieren
APA
Guthoff, H., Abdel-Wahab, M., Kim, W. K., Witberg, G., Wienemann, H., Thurow, M., Shamekhi, J., Eckel, C., von der Heide, I., Veulemans, V., Landt, M., Barbanti, M., Finkelstein, A., Schewel, J., Van Mieghem, N., Adrichem, R., Toggweiler, S., Rheude, T., Nombela-Franco, L., …, & IMPPACT TAVR Investigators (2024). Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions, 17(22), 2626-2635. https://doi.org/10.1016/j.jcin.2024.08.041
Vancouver
Guthoff H, Abdel-Wahab M, Kim WK, Witberg G, Wienemann H, Thurow M, et al. Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 2024;17(22):2626-2635. doi:10.1016/j.jcin.2024.08.041
BibTeX
@article{Guthoff2024,
author = {Guthoff, Henning and Abdel-Wahab, Mohamed and Kim, Won-Keun and Witberg, Guy and Wienemann, Hendrik and Thurow, Maria and Shamekhi, Jasmin and Eckel, Clemens and von der Heide, Ina and Veulemans, Verena and Landt, Martin and Barbanti, Marco and Finkelstein, Ariel and Schewel, Jury and Van Mieghem, Nicolas and Adrichem, Rik and Toggweiler, Stefan and Rheude, Tobias and Nombela-Franco, Luis and Amat-Santos, Ignacio J and Ruile, Philipp and Estévez-Loureiro, Rodrigo and Bunc, Matjaz and Branca, Luca and De Backer, Ole and Tarantini, Giuseppe and Mylotte, Darren and Arzamendi, Dabit and Pauly, Markus and Bleiziffer, Sabine and Renker, Matthias and Al-Kassou, Baravan and Möllmann, Helge and Ludwig, Sebastian and Zeus, Tobias and Tamburino, Corrado and Schmidt, Tobias and Rück, Andreas and von Stein, Philipp and Thiele, Holger and Abdelhafez, Ahmed and Adam, Matti and Baldus, Stephan and Rudolph, Tanja and Mauri, Victor and IMPPACT TAVR Investigators, IMPPACT TAVR Investigators},
title = {Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
volume = {17},
number = {22},
pages = {2626--2635},
doi = {10.1016/j.jcin.2024.08.041}
}
EUVIMED